Pfizer, Merck strike deal to develop cancer tumor treatment

/ / Published in Capital Market News

Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction.

Source : MarketWatchCom

What you can read next

The Moneyologist: Mother’s Day Moneyologist: Can I sue my mother for changing my last name?
Conte: Moses not a cheat
CPPL empowers growing businesses to create value